+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Oxidative stress, AGE, and atherosclerosis



Oxidative stress, AGE, and atherosclerosis



Kidney International. Supplement: S17-S26



Numerous reports on the molecular mechanism of atherogenesis indicate an increase in oxidative stress, formation of advanced glycoxidation end products (AGEs), chronic inflammation, and activated cellular response particularly in diabetic patients. To elucidate the initiating and early accelerating events this review will focus on the molecular causes of the induction of these stress factors, their interactions, and their contribution to atherogenesis. Metabolic factors such as elevated free fatty acids, high glucose levels or AGEs induce reactive oxygen species (ROS) in vascular cells leading to ongoing AGE formation and to gene induction of proinflammatory cytokines. Vice versa, numerous cytokines found elevated in obesity and diabetes may also induce oxidative stress thus a circulus vitious may be initiated and accelerated. Increased production of ROS, mainly from mitochondria and NAD(P)H oxidase, stimulates signaling cascades including protein kinase C and mitogen-activated protein kinase pathway leading to nuclear translocation of transcription factors such as nuclear factor-kappa B (NF-kappa B), activator protein 1, and specificity protein 1. Subsequently, the expression of numerous genes including cytokines is rapidly induced, which, in turn, may act on vascular cells promoting the deleterious effects. From animal models of accelerated atherosclerosis a causal role of NAD(P)H oxidase and the AGE/RAGE/NF-kappa B axis to atherogenesis is suggested. Because all factors involved form a highly interwoven network of interactions, the blockade of ROS or AGE formation at different sites may interrupt the vicious cycle. Promising candidate agents are, currently on trial. Most important to clinical practice, a number of drugs commonly used in the treatment of diabetes, hypertension, or cardiovascular disease, such as angiotensin-converting enzyme inhibitors, AT, receptor blockers, 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (statins), and thiazolidindiones have shown promising 'preventive' intracellular antioxidant activity in addition to their primary pharmacological actions.

Accession: 016594100

Download citation: RISBibTeXText

PMID: 17653206

DOI: 10.1038/sj.ki.5002382


Related references

Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation. Antioxidants 8(3), 2019

Oxidative Stress in Atherosclerosis Development The Central Role of LDL and Oxidative Burst. Endocrine Metabolic & Immune Disorders - Drug Targets 12(4): 351-360, 2012

Oxidative stress in atherosclerosis development: the central role of LDL and oxidative burst. Endocrine, Metabolic and Immune Disorders Drug Targets 12(4): 351-360, 2013

Increased inflammation, endoplasmic reticulum stress and oxidative stress in endothelial and macrophage cells exacerbate atherosclerosis in ApoCIII transgenic mice. Lipids in Health and Disease 17(1): 220, 2018

Oxidative stress and atherosclerosis. Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 752-756, 1997

Oxidative stress and atherosclerosis. Orvosi Hetilap 156(28): 1115-1119, 2015

Oxidative Stress in Atherosclerosis. Current Atherosclerosis Reports 19(11): 42, 2018

Oxidative stress and atherosclerosis. Pathophysiology 13(3): 129-142, 2006

Oxidative stress in atherosclerosis. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 107(3): 502-511, 2004

Atherosclerosis and oxidative stress. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 45(3): 287-290, 2008

Atherosclerosis and oxidative stress. Histology and Histopathology 23(3): 381-390, 2007

Insights into oxidative stress and atherosclerosis. Canadian Journal of Cardiology 16 Suppl D: 2d-4d, 2000

Oxidative stress in atherosclerosis and diabetes. Bulletin of Experimental Biology and Medicine 140(1): 41-43, 2005

Nox enzymes and oxidative stress in atherosclerosis. Frontiers in Bioscience 4: 651-670, 2013

The role of oxidative stress in atherosclerosis. Hellenic Journal of Cardiology 50(5): 402-409, 2009